Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,398,863
+$7,190,551 QoQ
Shares Held
124,479
+91.7% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 94.33077065207786.ToString("F0")%
Shared 0.ToString("F0")%
None 5.66922934792214.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $165,612,539 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
912,970 | $107,922,182 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
124,479 | $16,398,863 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
1,059,831 | $14,678,659 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
145,811 | $8,064,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
10,232 | $6,067,371 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
90,154 | $2,157,385 | |
| 7 | CGC |
Canopy Growth Corp
|
1,807,986 | $1,715,778 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
580,705 | $1,591,131 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,398,863 | 124,479 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,208,312 | 64,925 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,738,313 | 40,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,571,847 | 36,374 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,280,089 | 56,782 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,091,583 | 59,279 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,632,511 | 74,922 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,457,480 | 61,433 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,630,975 | 55,329 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $6,119,593 | 46,445 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,065,962 | 27,253 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $175,398 | 1,860 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,553,583 | 44,987 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $505,828 | 4,235 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $127,770 | 1,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $74,572 | 765 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $74,156 | 791 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,131,426 | 48,508 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,271,873 | 34,114 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $88,983 | 915 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $94,699 | 988 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $92,313 | 960 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $142,984 | 1,172 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $156,915 | 1,813 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||